Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size.
暂无分享,去创建一个
J. Després | N. Wareham | K. Khaw | J. Kastelein | S. Boekholdt | E. Stroes | I. Lemieux | B. Arsenault | J. Despres | J. Kastelein | N. Wareham | Benoit J. Arsenault | E. Stroes
[1] H. Superko. Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful , 2009, Circulation.
[2] Christina Lindahl,et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. , 2008, Journal of the American College of Cardiology.
[3] G. Assmann,et al. PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol , 2008, Clinical chemistry and laboratory medicine.
[4] J. Pais de Barros,et al. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. , 2007, Journal of the American College of Cardiology.
[5] J. Després,et al. Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. , 2007, European heart journal.
[6] James O. Mudd,et al. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease. , 2007, Journal of the American College of Cardiology.
[7] Anand Rohatgi,et al. HDL cholesterol: physiology, pathophysiology, and management. , 2007, Current problems in cardiology.
[8] W. Cromwell,et al. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. , 2006, Clinics in laboratory medicine.
[9] C. Heward,et al. Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. , 2006, Clinical chemistry.
[10] M. Taskinen,et al. Decreased High-Density Lipoprotein (HDL) Particle Size, Pre&bgr;-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[11] M. Rizzo,et al. Low-density lipoprotein size and cardiovascular risk assessment. , 2006, QJM : monthly journal of the Association of Physicians.
[12] Z. Bloomgarden. Dyslipidemia and the metabolic syndrome. , 2004, Diabetes care.
[13] M. Taskinen,et al. Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresiss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional two tables. Published, JLR Papers in Press, March 1, 2004. DOI 10.1194/jlr.M300395-JLR200 , 2004, Journal of Lipid Research.
[14] J. Després,et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. , 2003, Metabolism: clinical and experimental.
[15] P. Ridker,et al. Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women , 2002, Circulation.
[16] Mitsuyo Okazaki,et al. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. , 2002, Journal of lipid research.
[17] D. Mikhailidis,et al. Beyond LDL-C – The Importance of Raising HDL-C , 2002, Current medical research and opinion.
[18] J. Després,et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. , 2001, Journal of lipid research.
[19] G. Dagenais,et al. Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[20] C. Couillard,et al. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. , 2001, Journal of lipid research.
[21] N. Day,et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.
[22] G. Dagenais,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.
[23] R. Krauss,et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.
[24] J. Després,et al. The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.
[25] S. Bhakdi,et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety , 1995, The Journal of experimental medicine.
[26] G. Dagenais,et al. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study) , 1995, The American journal of cardiology.
[27] K. C. Tan,et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. , 1995, Atherosclerosis.
[28] T. Lyons,et al. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. , 1993, The American journal of cardiology.
[29] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.